Z16.12 - Extended spectrum beta lactamase (ESBL) resistance

  • Applicable to Extended spectrum beta lactamase (ESBL) resistance
  • The 2025 edition of ICD10-CM Z16.12 became effective on October 1, 2024.
  • This is the American ICD10-CM version of Z16.12 - other international versions of ICD10 Z16.12 may differ.
  • Z16.12 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Type 2 Excludes

  • Methicillin resistant Staphylococcus aureus infection in diseases classified elsewhere (B95.62)

The following codes above Z16.12 contain annotation back-references that may be applicable to Z16.12:

Chapter: Z00-Z99 Factors influencing health status and contact with health services

Section: Z16 Resistance to antimicrobial drugs

Category: Z16 Resistance to antimicrobial drugs

lactamase icd 10
 
resistance icd 10
 
antimicrobial icd 10
 
esbl icd 10
 
drugs icd 10
 
extended icd 10
 
beta icd 10
 
spectrum icd 10
 
Billable/Specific Code

Browse other similar CM codes

Z16.1
 
Z16.10
 
Z16.11
 
Z16.12
 
Z16.13
 
Z16.19
 
Z16.2
 
Z16.20
 
Z16.21
 
Z16.22
 
Z16.23
 
Z16.24
 
Z16.29
 
Z16.3
 
Z16.30
 
Z16.31
 
Z16.32
 
Z16.33
 
Z16.34
 
Z16.341
 
Z16.342
 
Z16.35
 
Z16.39
 

Please, give attribution to our website icd-10code.com